ALNYALNYLAM PHARMACEUTICALS INC
CUSIP 02043Q107 · common stock · Other share classes: 02043QAD9
4 tracked investors held ALNYLAM PHARMACEUTICALS INC (ALNY) at the end of Q3 2026, worth $532.6M in total. The largest holder was Dodge & Cox, with 0.3% of its portfolio. Lee Ainslie opened a new position this quarter.
Holders · Q3 2026
4
New holders
1
Value held
$532.6M
Quarter-end price (est.)
$246.74
Investors holding ALNY · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 0.27% | 2,006,492 | $495.1M | ADD+2.6% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.07% | 149,114 | $36.8M | ADD+254.6% |
| Murray Stahl Horizon Kinetics Asset Management LLC | 0.01% | 1,960 | $483.6K | REDUCE-9.6% |
| Lee Ainslie Maverick Capital Ltd | 0.00% | 907 | $223.8K | NEW |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Ken Fisher | 0.00% | 6,252 | $1.9M | EXIT |